Month: July 2021

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. COVID-19 cases are continuing to spike in communities where vaccination rates are low, leading to what CDC Director Rochelle P. Walensky, MD, called “a pandemic of the unvaccinated.” Walensky reported sobering numbers during a news conference Friday: The most recent 7-day
0 Comments
KENILWORTH, N.J. & MIAMI–(BUSINESS WIRE) July 12, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced today the presentation of previously announced Phase 2 interim results from two Phase 2/3 clinical trials (MOVe-OUT and MOVe-IN) of molnupiravir (MK-4482/EIDD-2801), an investigational oral antiviral therapeutic. The data were
0 Comments
FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock™ (belumosudil) 200 mg once daily (QD) for the treatment of adult and pediatric patients
0 Comments
In this article FB Dr. Nahid Bhadelia, founding director of the Center for Emerging Infectious Diseases at Boston University, told CNBC, that, medically, she agrees with President Joe Biden‘s assertion that platforms like Facebook are killing people by allowing Covid-19 vaccine misinformation on their services. “I think social media is playing a big role in amplifying
0 Comments
Researchers at Vanderbilt University Medical Center (VUMC) and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract. Each year in the United States circulating strains of the human norovirus are responsible for approximately 20 million
0 Comments
For-profit insurance companies have long been regarded as the ultimate offenders in medical profiteering. However, they distract from the unscrupulous involvement of private equity (PE) in medicine, a similarly culpable and even more insidious economic titan. PE is a unique, unregulated investment platform with the objective of aggressively generating short-term revenue for the firm and
0 Comments
The overactive bladder treatment mirabegron (Myrbetriq) is one of three new drugs to be linked to cases of drug-associated antineutrophil cytoplasmic antibody–associated vasculitis (DA-AAV) according to pharmacovigilance data. The other two drugs are the antiviral agent sofosbuvir (Sovaldi) and the tyrosine kinase inhibitor nintedanib (Ofev), which is indicated for chronic fibrosing interstitial lung diseases (ILDs)
0 Comments
Have you been hearing your kids say, “I’m bored” more often this summer? You’re not alone. Due to the limitations brought about by the pandemic, everyone’s bound to get bored, including kids. Past summers were spent playing outdoors with friends, exploring, riding bikes or swimming. But aside from the pandemic, kids today have also become heavily dependent on gadgets for entertainment. Take
0 Comments
Researchers have found that individuals with learning disabilities are more likely to suffer from severe cases of COVID-19 infection, with higher rates of hospitalization and mortality, which is exacerbated for individuals with profound disabilities such as Down’s syndrome and cerebral palsy. SARS-CoV-2 Virus. Image Credit: Corona Borealis Studio/Shutterstock.com Further evidence indicating symptom severity of COVID-19
0 Comments
Dr. Scott Gottlieb told CNBC on Friday he believes the U.S. is significantly undercounting the number of Covid delta infections, making it difficult to know whether the highly transmissible strain is causing higher-than-expected hospitalization and death rates. “We don’t know what the denominator is right now,” Gottlieb said in an interview on “Squawk Box.” “I
0 Comments
Among 6- and 7-year-olds who were born extremely preterm–before the 28th week of pregnancy–those who had more than two hours of screen time a day were more likely to have deficits in overall IQ, executive functioning (problem solving skills), impulse control and attention, according to a study funded by the National Institutes of Health. Similarly,
0 Comments
In COVID-19 hot spots across the country where the Delta variant is thriving and vaccine hesitancy is high, hospitals have continued to urge for more people to get vaccinated. In the case of Ozarks Healthcare, based in West Plains, Mo., the health system recently issued an impassioned plea for people to get vaccinated, even if
0 Comments
Summer farmer’s markets are full of fresh picked goodness from the farm. Last week I found Lots of green, yellow, and purple beans-also known as string beans. Eat them raw; steam them lightly and marinate in a vinaigrette dressing; sauté them with lots of garlic and sprinkle with some toasted pine nuts, slivered almonds, or walnuts;
0 Comments
Support me: 🖼️ Buy PDFs: http://armandoh.org/shop 💵 Patreon: http://www.patreon.com/armando 👕 Buy shirts: https://teespring.com/stores/ah-7 Social media: 📷 Instagram: http://instagram.com/armandohasudungan 🐦 Twitter: https://twitter.com/armandohasudung 📔 Facebook: https://www.facebook.com/ArmandoHasudungan Resources: 📕 Books: http://armandoh.org/resource 🎞️ Equipment: armandoh.org/armando-faigl You can send me mail: 📫 PO BOX 166, Randwick NSW 2031, Australia
0 Comments
Summer is upon us, which means more time outdoors, enjoying those lovely moments of good weather. We’ve put together 11 common myths around sun safety to help you through the summer months. Take a read through to help you keep your skin healthy and reduce your risk of serious sun damage. 1. MYTH: I can
0 Comments
Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. A lack of consensus in the evidence regarding the antiviral remdesivir (Veklury) to treat people with COVID-19 continues, leaving clinicians without clear direction on one of the few treatments for the illness approved under US Food and Drug Administration (FDA) emergency use authorization.
0 Comments
Antibody and T-cell immune responses strong and stable at eight months after immunization Demonstrated neutralizing antibody activity against the Delta variant (B.1.617.2) over time NEW BRUNSWICK, N.J., July 14, 2021 – Interim results from a Phase 1/2a sub-study published in the New England Journal of Medicine (NEJM) demonstrated that both humoral (antibody) and cellular (T-cell) immune responses generated by
0 Comments
tezepelumab Treatment for Asthma Tezepelumab Granted Priority Review By U.S. FDA THOUSAND OAKS, Calif., July 7, 2021 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and granted Priority Review for tezepelumab in the treatment of asthma. Tezepelumab is being developed by Amgen in collaboration with AstraZeneca. The FDA grants Priority
0 Comments
Regular Approval Based on Overall Survival Results from Confirmatory EV-301 Trial First and Only FDA-Approved Therapy for Urothelial Cancer Patients Who Are Cisplatin-Ineligible and Have Previously Received One or More Prior Therapies, Based on Cohort 2 of Pivotal EV-201 Trial TOKYO and BOTHELL, Wash., July 9, 2021 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President
0 Comments